Serum fructosamine in diabetic pregnancy.
Serum fructosamine was measured in 275 blood donors, in 559 subjects with a normal pregnancy, in 32 gestational diabetics being treated with insulin and 69 being treated by diet only, and in 53 pregnant subjects with established diabetes. In none of the pregnant subgroups did the mean fructosamine concentration exceed that of the donor group. The concentration in normal pregnant subjects showed a modest but significant decrease with gestational age and an increase with maternal age. Hyperglycemic non-pregnant subjects (n = 24) had significantly increased serum fructosamine concentrations, and 96% of these subjects exceeded the upper 95% confidence limit for fructosamine in the donor group. A highly significant correlation was demonstrated between serum fructosamine and preprandial plasma glucose in the hyperglycemic subjects. A weak, but significant, correlation was shown for the entire population sample of antenatal patients, while this was non-significant within each of the sub-groups comprising established diabetics and gestational diabetics, respectively.
Frandsen
E K
EK
Department of Pathology, Riyadh Armed Forces Hospital, Kingdom of Saudi Arabia.
Sabagh
T
T
Bacchus
R A
RA
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D019270:Fructosamine; D017127:Glycation End Products, Advanced; D006031:Glycosylation; D006595:Hexosamines / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000097:blood* / Q000188:drug therapy; D012016:Reference Values; D012044:Regression Analysis; D012709:Serum Albumin / Q000378:metabolism; D000093423:Glycated Serum Albumin
D001786:Blood Glucose; D017127:Glycation End Products, Advanced; D006595:Hexosamines; D007328:Insulin; D012709:Serum Albumin; D019270:Fructosamine; D000093423:Glycated Serum Albumin